Archive Press Releases

04.11.2008

Epigenomics AG Reports Q3 and Nine Month 2008 Results

27.10.2008

Epigenomics AG Reports PRESEPT Clinical Study Progress

27.10.2008

Epigenomics AG Reports PRESEPT Clinical Study Progress

16.10.2008

Epigenomics AG Reports Successful Completion and Positive Results from Prostate Cancer Clinical Study

08.09.2008

Epigenomics Reports Positive Interim Results in Prostate Cancer Clinical Study

05.08.2008

Epigenomics AG Reports First Half of 2008 Results

29.07.2008

Epigenomics AG Receives Allowance for Key Patent in Europe

30.06.2008

First Subjects Enrolled in Epigenomics sponsored PRESEPT Colorectal Cancer Screening Study

18.06.2008

Epigenomics Successfully Completes Larger Clinical Study in Early Lung Cancer Detection

09.06.2008

Epigenomics Successfully Completes Clinical Study in Lung Cancer Diagnosis

06.05.2008

Epigenomics AG Reports First Quarter 2008 Financial Results

21.04.2008

Epigenomics AG Successfully Validates Optimized Blood-Based Colorectal Cancer Assay in two Independent Clinical Studies

14.04.2008

Epigenomics AG Presents Data on Novel Prostate Cancer Biomarkers at AACR

01.04.2008

Epigenomics and TIB MOLBIOL Launch First in a Series of Products at Analytica 2008

31.03.2008

Epigenomics AG Reports Financial Results for a Successful Fiscal Year 2007

13.03.2008

Epigenomics AG to host Press Conference and Analyst Meeting for 2007 Annual Results

19.02.2008

Epigenomics Licenses Septin 9 Colorectal Cancer Biomarker to Quest Diagnostics

21.01.2008

Epigenomics AG Expands Medical Advisory Board for Colorectal Cancer Screening

14.01.2008

Epigenomics AG Licenses Several Key Technologies to OncoMethylome Sciences S.A.

14.01.2008

Epigenomics AG and DxS Ltd. Enter Into Strategic Cross-Licensing Agreement

20.11.2007

Epigenomics Updates on Competitive Positioning

31.10.2007

Epigenomics AG Reports Third Quarter 2007 Results

10.10.2007

Epigenomics AG Forms Medical Advisory Board for Colorectal Cancer Screening

04.10.2007

Epigenomics AG: Key Patents for Cancer Testing Granted

18.09.2007

Epigenomics AG Updates on Progress in its Prostate Cancer Test Development Program

1-25 26-50 51-75 76-99 Next >